Status:
UNKNOWN
Continuous Ambulatory ECG Monitoring for Detection of Postoperative Atrial Fibrillation Following Thoracic Surgery
Lead Sponsor:
University of Manitoba
Conditions:
Lung Cancer
Atrial Fibrillation
Eligibility:
All Genders
55+ years
Brief Summary
Atrial fibrillation (AF) is a common and serious complication after lung resection. The incidence is likely underestimated, and risk may persist after leaving hospital. Recent development of simple we...
Detailed Description
Postoperative atrial fibrillation (POAF) is a serious complication that can occur after thoracic surgery. A substantial proportion of AF is clinically silent, detectable only by ECG monitoring. Despit...
Eligibility Criteria
Inclusion
- Adult patients, age ≥ 55 years at time of surgery, undergoing thoracic surgery with general anesthesia
- Co-enrolment in the NT-proBNP biomarker monitoring study
Exclusion
- Patients with a prior history of documented AF
- Patients with an implanted pacemaker or defibrillator
- Patients currently taking anti-arrhythmic medication other than ß- blockers, calcium channel blockers or digoxin
- Patients undergoing minor thoracic interventions/procedures (i.e., minor chest-wall surgeries, chest tube insertions, or needle pleural/lung biopsies)
- Patients who are unable or unwilling to wear the CardioSTAT device as per manufacturer's guidelines, or who are unable/unwilling to return the device via mail to Icentia for procession and analysis
- Patients with known allergy to adhesives
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04325269
Start Date
April 1 2020
End Date
June 1 2021
Last Update
April 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Sciences Centre
Winnipeg, Manitoba, Canada, R3A1R9